News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
CompuMed Engages Liolios Group to Lead New Investor Relations Program
February 9, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES--(BUSINESS WIRE)--CompuMed, Inc. (OTCBB:CMPD) (http://www.compumed.net), a medical informatics and software company, has engaged Liolios Group, Inc. to help lead the company’s new investor relations and financial communications program.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoff Tracker
GSK Cuts 8 Employees in San Francisco
October 2, 2025
·
211 min read
·
BioSpace Editorial Staff
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
October 2, 2025
·
2 min read
·
Tristan Manalac
Cancer
AnaptysBio Plans Business Split To Sharpen Focus on Asset Value
October 1, 2025
·
2 min read
·
Tristan Manalac
Business
Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO
October 1, 2025
·
2 min read
·
Tristan Manalac